Wedbush Securities Inc Eli Lilly & CO Transaction History

Wedbush Securities Inc

  • $2.7 Billion
  • Q3 2024

A detailed history of Wedbush Securities Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Wedbush Securities Inc holds 20,559 shares of LLY stock, worth $16 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
20,559
Previous 24,501 16.09%
Holding current value
$16 Million
Previous $22.2 Million 17.89%
% of portfolio
0.68%
Previous 0.79%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$772.14 - $960.02 $3.04 Million - $3.78 Million
-3,942 Reduced 16.09%
20,559 $18.2 Million
Q2 2024

Aug 06, 2024
BUY
$724.87 - $909.04 $586,419 - $735,413
809 Added 3.41%
24,501 $22.2 Million
Q1 2024

May 14, 2024
BUY
$592.2 - $792.28 $1.76 Million - $2.35 Million
2,967 Added 14.32%
23,692 $18.4 Million
Q4 2023

Feb 12, 2024
BUY
$525.19 - $619.13 $1 Million - $1.18 Million
1,906 Added 10.13%
20,725 $12.1 Million
Q3 2023

Nov 14, 2023
BUY
$434.7 - $599.3 $850,707 - $1.17 Million
1,957 Added 11.61%
18,819 $10.1 Million
Q2 2023

Aug 14, 2023
BUY
$350.74 - $468.98 $903,856 - $1.21 Million
2,577 Added 18.04%
16,862 $7.91 Million
Q1 2023

May 09, 2023
SELL
$310.63 - $364.82 $197,871 - $232,390
-637 Reduced 4.27%
14,285 $4.91 Million
Q4 2022

Jan 31, 2023
BUY
$321.55 - $374.67 $455,957 - $531,282
1,418 Added 10.5%
14,922 $5.46 Million
Q3 2022

Oct 18, 2022
BUY
$296.48 - $337.87 $332,354 - $378,752
1,121 Added 9.05%
13,504 $4.37 Million
Q2 2022

Jul 21, 2022
BUY
$278.73 - $327.27 $215,737 - $253,306
774 Added 6.67%
12,383 $4.01 Million
Q1 2022

Apr 19, 2022
BUY
$234.69 - $291.66 $87,774 - $109,080
374 Added 3.33%
11,609 $3.32 Million
Q4 2021

Jan 13, 2022
BUY
$224.85 - $279.04 $1.32 Million - $1.64 Million
5,887 Added 110.08%
11,235 $3.1 Million
Q3 2021

Oct 08, 2021
BUY
$221.6 - $272.71 $10,636 - $13,090
48 Added 0.91%
5,348 $1.24 Million
Q2 2021

Jul 27, 2021
SELL
$180.55 - $233.54 $133,245 - $172,352
-738 Reduced 12.22%
5,300 $1.22 Million
Q1 2021

Apr 26, 2021
BUY
$164.32 - $212.72 $249,109 - $322,483
1,516 Added 33.52%
6,038 $1.13 Million
Q4 2020

Feb 16, 2021
BUY
$130.46 - $172.63 $8,740 - $11,566
67 Added 1.5%
4,522 $763,000
Q3 2020

Oct 20, 2020
SELL
$146.22 - $169.13 $31,291 - $36,193
-214 Reduced 4.58%
4,455 $659,000
Q2 2020

Jul 16, 2020
SELL
$136.42 - $164.18 $16,506 - $19,865
-121 Reduced 2.53%
4,669 $766,000
Q1 2020

Apr 17, 2020
SELL
$119.05 - $147.35 $135,717 - $167,979
-1,140 Reduced 19.22%
4,790 $665,000
Q4 2019

Jan 16, 2020
SELL
$106.92 - $132.43 $7,591 - $9,402
-71 Reduced 1.18%
5,930 $779,000
Q3 2019

Oct 17, 2019
BUY
$106.79 - $116.16 $63,753 - $69,347
597 Added 11.05%
6,001 $671,000
Q2 2019

Aug 01, 2019
SELL
$110.79 - $129.32 $50,631 - $59,099
-457 Reduced 7.8%
5,404 $599,000
Q1 2019

Apr 17, 2019
SELL
$111.31 - $131.02 $8,348 - $9,826
-75 Reduced 1.26%
5,861 $761,000
Q4 2018

Jan 31, 2019
SELL
$105.9 - $118.64 $87,791 - $98,352
-829 Reduced 12.25%
5,936 $687,000
Q3 2018

Nov 13, 2018
SELL
$85.86 - $107.31 $113,249 - $141,541
-1,319 Reduced 16.32%
6,765 $726,000
Q2 2018

Aug 03, 2018
SELL
$75.7 - $86.88 $35,049 - $40,225
-463 Reduced 5.42%
8,084 $690,000
Q1 2018

May 01, 2018
SELL
$74.21 - $87.6 $235,765 - $278,305
-3,177 Reduced 27.1%
8,547 $661,000
Q4 2017

Feb 09, 2018
SELL
$81.94 - $87.89 $74,237 - $79,628
-906 Reduced 7.17%
11,724 $990,000
Q3 2017

Oct 31, 2017
BUY
$77.07 - $85.54 $973,394 - $1.08 Million
12,630
12,630 $1.08 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
752M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email